Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Adjuvanted vs Conventional Influenza Vaccine in Elderly
NCT00310648Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza, sponsored by Novartis. Started Jan 2006; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00310648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310648.